Top Markets
Coin of the day
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

600196
Rang in Aktien #2384
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Aktienkurs
$3.34
Marktkapitalisierung
$8.80B
Veränderung (1 Tag)
1.01%
Veränderung (1 Jahr)
-18.10%
Land
CN
Handel Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)

Kategorie

Kursverlauf für Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Höchster Schlusskurs: $3.47 am 2026-08-01

Niedrigster Schlusskurs: $0.36 am 1998-08-01
Kursverlauf der Aktie von Shanghai Fosun Pharmaceutical (Group) Co., Ltd. von 1998 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -2.50%
2025 8.14%
2024 -0.94%
2023 -31.28%
2022 -34.31%
2021 -5.07%
2020 129.33%
2019 -1.62%
2018 -42.79%
2017 96.94%
2016 -12.63%
2015 10.13%
2014 13.54%
2013 95.36%
2012 11.98%
2011 -35.14%
2010 13.21%
2009 101.27%
2008 -23.82%
2007 209.65%
2006 36.28%
2005 -4.95%
2004 -0.52%
2003 4.10%
2002 -19.96%
2001 -30.79%
2000 45.49%
1999 -23.09%
1998 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$165.29 29.31%
DE
$37.93 24.19%
JP
$223.18 31.21%
CH
$21.21 12.17%
IN